JAZZ — Jazz Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $13.92bn
- $16.07bn
- $4.27bn
U.S. STOCKS ON THE MOVE-BWX Technologies, Synopsys,Burlington Stores
U.S. STOCKS ON THE MOVE-Jazz Pharmaceuticals, Celularity, Infleqtion
Jazz Pharma dips after upsized $1.1 bln convertible offering
Brief: Jazz Pharmaceuticals Announces Private Offering Of $1.0 Billion Of Exchangeable Senior Notes Due 2032
U.S. RESEARCH ROUNDUP- Intuit, MongoDB, Zscaler
Brief: FDA Approves Ziihera For Her2+ Advanced Gastroesophageal Cancer
U.S. RESEARCH ROUNDUP-Cardinal Health, Lumentum Holdings, Public Storage
Jazz bets on epilepsy treatment with up to $1.32 billion deal for Actio (updated)
Brief: Jazz Pharmaceuticals To Acquire Actio Biosciences, Expanding Rare Epilepsy Portfolio
Jazz bets on epilepsy treatment with up to $1.32 billion deal for Actio
U.S. RESEARCH ROUNDUP-Cloudflare, Replimune, Walmart
Jazz Pharmaceuticals PLC reports results for the quarter ended June 30 - Earnings Summary
Ireland's Jazz Pharma Q2 revenue beats estimates on Zepzelca higher sales
Brief: Jazz Pharmaceuticals Q2 Adjusted EPS USD 5.71 Vs. IBES Estimate USD 6.18
U.S. RESEARCH ROUNDUP-IBM, MSCI, US Bancorp
Analysis: US prices for new drugs fell in 2025 as fewer costly gene therapies were launched
Jazz Pharma, AbCellera ink antibody deal worth up to $876 million
Brief: Jazz Pharmaceuticals Delivers Extensive Late-Breaking Data At Sleep 2026, Demonstrating Real-World Impact Of Xywav
U.S. STOCKS ON THE MOVE-SpaceX, Tesla, Woodside Energy Group